Lynette W Lissin, MD
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 14
- 4 carriers
- Offices
- 2
Offices
2 locations · Stanford Health Care · Sutter Bay Medical Foundation
Looking this up.
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
14 plans · 4 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Lissin’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
14 of 14 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A60327 · Current
Licensed to practise in California · since 1996 · expires 2028-06-30 · Harvard Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$219,397
Medicare paid this office $219,397 for 2,068 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 336 | $63,813 | $189 |
| Return visit (30+ min) | 339 | $58,062 | $108 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 114 | $26,279 | $231 |
| Long return visit (40+ min) | 70 | $12,928 | $156 |
| New patient visit (45+ min) | 65 | $9,360 | $144 |
See all 16 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 336 | $63,813 | $189 |
| Return visit (30+ min) | 339 | $58,062 | $108 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 114 | $26,279 | $231 |
| Long return visit (40+ min) | 70 | $12,928 | $156 |
| New patient visit (45+ min) | 65 | $9,360 | $144 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 41 | $8,530 | $105 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 686 | $8,120 | $7 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 287 | $6,344 | $15 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 502 | $6,318 | $12 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 32 | $5,093 | $154 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 134 | $3,160 | $23 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 21 | $1,974 | $70 |
| Heart rhythm recording of continous external ekg over 8-15 days | 130 | $1,733 | $13 |
| Short return visit (20+ min) | 12 | $1,010 | $78 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 15 | $309 | $21 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 15 | $198 | $13 |
Who their Medicare patients are
2,068 Original Medicare patients in 2024. Average age 76 · Under 65 5% · 85 and older 18% · Women 52% · Also on Medicaid 16% · Health risk score 1.59. At or below the middle of the specialty; the typical advanced heart failure and transplant cardiology clinician is at 2.53.
Conditions among them: High blood pressure 75% · Coronary heart disease 43% · Atrial fibrillation 41% · Chronic kidney disease 33% · Heart failure 31% · Diabetes 28% · Depression 21% · Cancer 19% · COPD 14% · Dementia 13% · Stroke 12%.
The office billed $991,737, Medicare allowed $300,044 and paid $219,397; for 3,779 services of 36 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 2,068 | 3,779 | 76 | 1.59 | $991,737 | $219,397 |
| 2023 | 1,553 | 2,454 | 78 | 1.43 | $729,963 | $180,022 |
| 2022 | 1,722 | 2,878 | 78 | 1.32 | $802,880 | $205,917 |
| 2021 | 1,527 | 2,569 | 78 | 1.26 | $757,345 | $213,096 |
| 2020 | 1,177 | 2,087 | 78 | 1.28 | $600,993 | $163,781 |
| 2019 | 1,599 | 2,690 | 77 | 1.27 | $846,483 | $218,236 |
| 2018 | 1,802 | 2,812 | 77 | 1.28 | $912,160 | $230,587 |
| 2017 | 1,794 | 2,957 | 77 | 1.28 | $1,045,491 | $284,238 |
| 2016 | 1,578 | 2,563 | 77 | 1.31 | $767,491 | $207,539 |
| 2015 | 1,438 | 3,027 | 77 | 1.41 | $797,860 | $232,786 |
| 2014 | 1,609 | 3,592 | 76 | 1.18 | $921,699 | $254,523 |
| 2013 | 1,577 | 3,257 | 76 | 1.27 | $861,183 | $209,547 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 18 services
| Return visit (30+ min) | 314 | $55,242 | $114 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 232 | $45,896 | $198 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 96 | $22,001 | $229 |
| Long return visit (40+ min) | 84 | $17,200 | $162 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 38 | $6,803 | $106 |
| New patient visit (45+ min) | 36 | $5,596 | $155 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 35 | $5,418 | $151 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 377 | $4,999 | $13 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 430 | $3,491 | $6 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 98 | $2,367 | $24 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 19 | $2,116 | $71 |
| Heart rhythm recording of continous external ekg over 8-15 days | 94 | $1,263 | $13 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 17 | $641 | $25 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 14 | $303 | $22 |
| Blood test, clotting time | 39 | $298 | $4 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 11 | $270 | $25 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 14 | $186 | $13 |
| Anticoagulant management of patient taking warfarin | 19 | $168 | $8 |
2022: 14 services
| Return visit (30+ min) | 320 | $55,580 | $113 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 234 | $46,993 | $198 |
| Long return visit (40+ min) | 139 | $31,398 | $158 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 120 | $28,822 | $240 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 40 | $7,270 | $91 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 35 | $6,534 | $181 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 436 | $5,569 | $12 |
| New patient visit (45+ min) | 42 | $5,534 | $132 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 545 | $5,293 | $7 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 97 | $2,477 | $25 |
| Heart rhythm recording of continous external ekg over 8-15 days | 95 | $1,497 | $16 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 36 | $720 | $19 |
| Blood test, clotting time | 44 | $348 | $4 |
| Anticoagulant management of patient taking warfarin | 28 | $340 | $8 |
2021: 18 services
| Return visit (30+ min) | 301 | $52,862 | $117 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 234 | $49,525 | $209 |
| Long return visit (40+ min) | 166 | $42,416 | $160 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 90 | $21,899 | $243 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 37 | $7,136 | $183 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 37 | $6,569 | $95 |
| New patient visit (45+ min) | 38 | $5,952 | $157 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 410 | $5,839 | $14 |
| New patient visit (60+ min) | 20 | $3,330 | $167 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 334 | $3,084 | $7 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 108 | $2,787 | $25 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 59 | $1,709 | $22 |
| Heart rhythm recording of continous external ekg over 8-15 days | 101 | $1,704 | $16 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 20 | $1,655 | $66 |
| Telephone medical discussion with physician, 11-20 minutes | 11 | $742 | $62 |
| Heart muscle strain imaging | 12 | $521 | $43 |
| 3d radiographic procedure | 16 | $376 | $24 |
| Blood test, clotting time | 48 | $335 | $4 |
2020: 19 services
| Return visit (30+ min) | 290 | $49,035 | $98 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 185 | $38,139 | $206 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 93 | $21,289 | $229 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 37 | $6,977 | $189 |
| Long return visit (40+ min) | 42 | $6,958 | $131 |
| Telephone medical discussion with physician, 11-20 minutes | 74 | $6,627 | $74 |
| New patient visit (45+ min) | 42 | $5,768 | $137 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 31 | $5,068 | $97 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 294 | $4,600 | $15 |
| Short return visit (20+ min) | 47 | $3,808 | $67 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 234 | $2,229 | $8 |
| Telephone medical discussion with physician, 21-30 minutes | 15 | $1,888 | $111 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 17 | $1,348 | $67 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 48 | $1,220 | $25 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 44 | $1,066 | $20 |
| External ekg recording for more than 48 hours up to 21 days | 35 | $1,025 | $28 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 27 | $761 | $27 |
| Blood test, clotting time | 57 | $341 | $4 |
| Injection, dobutamine hydrochloride, per 250 mg | 11 | $51 | None |
2019: 17 services
| Return visit (30+ min) | 376 | $61,933 | $95 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 298 | $60,660 | $202 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 127 | $29,376 | $231 |
| Long return visit (40+ min) | 73 | $13,696 | $129 |
| New patient visit (45+ min) | 61 | $8,574 | $141 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 47 | $8,399 | $175 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 502 | $7,558 | $15 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 45 | $6,848 | $94 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 37 | $4,176 | $66 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 85 | $2,699 | $22 |
| External ekg recording for more than 48 hours up to 21 days | 65 | $1,776 | $27 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 20 | $1,709 | $81 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 65 | $1,583 | $24 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 151 | $1,308 | $7 |
| Blood test, clotting time | 108 | $792 | $4 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 14 | $379 | $27 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 14 | $193 | $14 |
2018: 16 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 336 | $68,922 | $202 |
| Return visit (30+ min) | 377 | $59,175 | $90 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 135 | $30,007 | $221 |
| Long return visit (40+ min) | 109 | $15,150 | $121 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 603 | $9,169 | $15 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 41 | $7,774 | $181 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 51 | $7,065 | $92 |
| New patient visit (45+ min) | 41 | $5,791 | $141 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 42 | $4,837 | $63 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 42 | $3,655 | $85 |
| External ekg recording for more than 48 hours up to 21 days | 83 | $2,350 | $27 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 259 | $2,345 | $7 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 83 | $2,032 | $24 |
| Short return visit (20+ min) | 13 | $959 | $68 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 13 | $794 | $61 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 14 | $189 | $13 |
2017: 19 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 368 | $80,015 | $215 |
| Return visit (30+ min) | 336 | $60,221 | $94 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 152 | $39,991 | $263 |
| Long return visit (40+ min) | 114 | $16,714 | $128 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 29 | $14,141 | $488 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 60 | $11,068 | $173 |
| New patient visit (45+ min) | 65 | $9,571 | $147 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 595 | $8,689 | $14 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 45 | $6,076 | $93 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 30 | $5,725 | $95 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 52 | $4,408 | $83 |
| Injection, regadenoson, 0.1 mg | 27 | $4,295 | None |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 36 | $4,081 | $65 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 45 | $2,986 | $66 |
| External ekg recording for more than 48 hours up to 21 days | 68 | $1,942 | $28 |
| Ultrasound of heart, follow-up | 14 | $1,730 | $108 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 68 | $1,704 | $24 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 184 | $1,442 | $6 |
| Short return visit (20+ min) | 13 | $1,029 | $69 |
2016: 20 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 256 | $56,980 | $221 |
| Return visit (30+ min) | 308 | $52,156 | $92 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 94 | $24,403 | $254 |
| Long return visit (40+ min) | 60 | $8,629 | $129 |
| New patient visit (45+ min) | 57 | $8,201 | $144 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 16 | $7,601 | $475 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 510 | $7,513 | $14 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 30 | $5,588 | $180 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 45 | $5,144 | $64 |
| Short return visit (20+ min) | 82 | $4,733 | $53 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 28 | $4,167 | $93 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 46 | $3,587 | $78 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 16 | $3,053 | $95 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 224 | $1,955 | $7 |
| Injection, regadenoson, 0.1 mg | 11 | $1,858 | None |
| External ekg recording for more than 48 hours up to 21 days | 54 | $1,470 | $27 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 13 | $1,458 | $112 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 22 | $1,340 | $61 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 54 | $1,265 | $23 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 14 | $183 | $13 |
2015: 20 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 303 | $69,216 | $228 |
| Return visit (30+ min) | 320 | $49,995 | $96 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 137 | $38,189 | $273 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 20 | $9,931 | $497 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 50 | $9,757 | $188 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 24 | $5,875 | $235 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 38 | $5,863 | $96 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 54 | $5,844 | $68 |
| Short return visit (20+ min) | 76 | $5,753 | $68 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 21 | $5,311 | $130 |
| Long return visit (40+ min) | 38 | $5,306 | $136 |
| New patient visit (45+ min) | 33 | $5,012 | $152 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 345 | $3,384 | $7 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 210 | $3,087 | $15 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 27 | $1,755 | $65 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,538 | $128 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 11 | $943 | $86 |
| External ekg recording for more than 48 hours up to 21 days | 25 | $730 | $29 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 23 | $578 | $25 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 19 | $546 | None |
2014: 19 services
| Return visit (30+ min) | 326 | $57,112 | $96 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 223 | $49,632 | $222 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 121 | $32,880 | $272 |
| External ekg recording for more than 48 hours up to 21 days with analysis, report, review and interpretation | 83 | $19,727 | $235 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 34 | $15,384 | $452 |
| Long return visit (40+ min) | 91 | $11,911 | $125 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 596 | $9,154 | $15 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 34 | $8,763 | $129 |
| New patient visit (45+ min) | 57 | $8,615 | $151 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 45 | $6,932 | $92 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 44 | $6,277 | $64 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 69 | $5,708 | $82 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 28 | $5,035 | $174 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 40 | $2,478 | $62 |
| Injection, adenosine for diagnostic use, 1 mg (not to be used to report any adenosine phosphate compounds, instead use a9270) | 31 | $2,299 | None |
| Short return visit (20+ min) | 30 | $2,250 | $68 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 141 | $1,385 | $7 |
| Extended office or other outpatient service, first hour | 12 | $1,079 | $90 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 34 | $443 | $13 |
2013: 24 services
| Return visit (30+ min) | 288 | $48,918 | $91 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 214 | $37,770 | $174 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 42 | $20,298 | $298 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 84 | $18,648 | $217 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 81 | $9,979 | $83 |
| Long return visit (40+ min) | 65 | $8,936 | $119 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 43 | $8,730 | $132 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 513 | $8,263 | $16 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 200 | $5,920 | $15 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 30 | $5,600 | $175 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 45 | $5,433 | $62 |
| Short return visit (20+ min) | 53 | $3,977 | $61 |
| External ekg recording for more than 48 hours up to 21 days with analysis, report, review and interpretation | 16 | $3,841 | $240 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 56 | $3,503 | $63 |
| New patient visit (45+ min) | 21 | $3,170 | $151 |
| Blood test, clotting time | 245 | $2,955 | $5 |
| Injection, adenosine for diagnostic use, 30 mg (not to be used to report any adenosine phosphate compounds; instead use a9270) | 34 | $2,926 | None |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 21 | $2,880 | $90 |
| Extended office or other outpatient service, first hour | 16 | $1,412 | $88 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 81 | $813 | $7 |
| Ultrasound of heart blood flow, valves and chambers | 12 | $507 | $42 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 31 | $394 | $13 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 12 | $232 | $19 |
| Injection, dobutamine hydrochloride, per 250 mg | 12 | $71 | None |
Medicaid work
$9,476 in 2024
Medicaid paid $9,476 for 875 billed services this clinician did in 2024, up to 103 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 875 | $9,476 |
| 2024 | 875 | 1 | 103 | $9,476 |
| 2023 | 208 | 1 | 47 | $1,678 |
| 2022 | 247 | 1 | 54 | $1,837 |
| 2021 | 130 | 1 | 35 | $1,284 |
| 2020 | 79 | 1 | 33 | $959 |
| 2018 | 123 | 3 | 27 | $1,793 |
See the largest Medicaid services in earlier years
2023
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 208 | $1,678 |
2022
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 247 | $1,837 |
2021
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 130 | $1,284 |
2020
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 79 | $959 |
2018
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 96 | $1,169 |
| Return visit (30+ min) | 14 | $438 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 13 | $186 |
Drugs they prescribed that Part D paid
$1,002,706
Pharmacies billed $1,002,706 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 3,932) in 2024. At or below the middle of the specialty; the typical advanced heart failure and transplant cardiology clinician is at 0%.
3,083 generic and 849 brand-name prescriptions · $1,002,706 in drug cost · 22 antibiotic prescriptions to 15 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 453 | $549,658 | $1,213 |
| Entresto | 142 | $157,006 | $1,106 |
| Jardiance | 88 | $91,526 | $1,040 |
| Xarelto | 40 | $59,811 | $1,495 |
| Repatha Sureclick | 50 | $48,599 | $972 |
See all 39 drugs
| Eliquis | 453 | $549,658 | $1,213 |
| Entresto | 142 | $157,006 | $1,106 |
| Jardiance | 88 | $91,526 | $1,040 |
| Xarelto | 40 | $59,811 | $1,495 |
| Repatha Sureclick | 50 | $48,599 | $972 |
| Farxiga | 25 | $28,400 | $1,136 |
| Metoprolol | 373 | $6,229 | $17 |
| Atorvastatin | 493 | $5,537 | $11 |
| Losartan | 259 | $3,327 | $13 |
| Ezetimibe | 107 | $2,724 | $25 |
| Rosuvastatin | 175 | $2,691 | $15 |
| Carvedilol | 195 | $1,899 | $10 |
| Valsartan | 41 | $1,786 | $44 |
| Spironolactone-Hctz | 46 | $1,652 | $36 |
| Amiodarone | 53 | $1,578 | $30 |
| Amlodipine Besylate | 225 | $1,491 | $7 |
| Clopidogrel | 75 | $1,365 | $18 |
| Digoxin | 31 | $1,156 | $37 |
| Diltiazem 24hr Er (Cd) | 42 | $1,089 | $26 |
| Lisinopril | 112 | $947 | $8 |
| Spironolactone | 102 | $802 | $8 |
| Potassium Chloride | 51 | $703 | $14 |
| Olmesartan Medoxomil | 31 | $635 | $20 |
| Atenolol | 33 | $598 | $18 |
| Isosorbide Mononitrate Er | 19 | $548 | $29 |
| Furosemide | 77 | $546 | $7 |
| Warfarin | 42 | $516 | $12 |
| Simvastatin | 48 | $437 | $9 |
| Metoprolol | 54 | $398 | $7 |
| Nebivolol | 12 | $394 | $33 |
| Levothyroxine | 23 | $359 | $16 |
| Nitroglycerin | 31 | $324 | $10 |
| Hydrochlorothiazide | 58 | $317 | $5 |
| Verapamil Er | 14 | $309 | $22 |
| Hydralazine | 34 | $279 | $8 |
| Pravastatin | 23 | $238 | $10 |
| Benazepril | 14 | $210 | $15 |
| Chlorthalidone | 16 | $149 | $9 |
| Amoxicillin | 19 | $34 | $2 |
Year by year
| 2024 | 3,932 | 439 | 0% (0) | 22% | $1,002,706 |
| 2023 | 4,089 | 451 | 0% (0) | 18% | $1,135,954 |
| 2022 | 4,136 | 456 | 0% (0) | 17% | $1,020,068 |
| 2021 | 3,944 | 420 | 0% (0) | 17% | $827,815 |
| 2020 | 3,979 | 420 | 0% (0) | None | $508,562 |
| 2019 | 4,066 | 461 | 0% (0) | 15% | $472,659 |
| 2018 | 4,069 | 456 | 0% (0) | 13% | $349,429 |
| 2017 | 4,042 | 432 | 0% (0) | 16% | $264,843 |
| 2016 | 3,815 | 379 | 0% (0) | 18% | $207,667 |
| 2015 | 3,661 | 362 | 0% (0) | 21% | $198,348 |
| 2014 | 3,502 | 350 | None | 20% | $167,656 |
| 2013 | 3,610 | 328 | 0% (0) | None | $215,171 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 43 drugs
| Eliquis | 434 | $529,918 | $1,221 |
| Vyndaqel | 11 | $222,655 | $20,241 |
| Entresto | 88 | $100,471 | $1,142 |
| Xarelto | 61 | $77,425 | $1,269 |
| Jardiance | 44 | $68,291 | $1,552 |
| Repatha Sureclick | 51 | $35,970 | $705 |
| Metoprolol | 413 | $8,090 | $20 |
| Atorvastatin | 566 | $7,293 | $13 |
| Rosuvastatin | 172 | $6,908 | $40 |
| Valsartan | 47 | $4,675 | $99 |
| Losartan | 275 | $4,595 | $17 |
| Ezetimibe | 84 | $2,790 | $33 |
| Carvedilol | 217 | $2,690 | $12 |
| Amiodarone | 61 | $1,905 | $31 |
| Amlodipine Besylate | 234 | $1,901 | $8 |
| Diltiazem 24hr Er (Cd) | 50 | $1,733 | $35 |
| Olmesartan Medoxomil | 33 | $1,721 | $52 |
| Potassium Chloride | 70 | $1,473 | $21 |
| Spironolactone-Hctz | 35 | $1,406 | $40 |
| Lisinopril | 124 | $1,251 | $10 |
| Digoxin | 38 | $1,168 | $31 |
| Spironolactone | 101 | $1,120 | $11 |
| Irbesartan | 19 | $1,092 | $57 |
| Furosemide | 114 | $1,058 | $9 |
| Isosorbide Mononitrate Er | 22 | $969 | $44 |
| Nitroglycerin | 34 | $838 | $25 |
| Clopidogrel | 49 | $772 | $16 |
| Isosorbide Dinitrate | 12 | $743 | $62 |
| Warfarin | 39 | $612 | $16 |
| Metoprolol | 58 | $571 | $10 |
| Atenolol | 35 | $509 | $15 |
| Hydralazine | 48 | $472 | $10 |
| Pravastatin | 20 | $461 | $23 |
| Hydrochlorothiazide | 68 | $418 | $6 |
| Levothyroxine | 28 | $387 | $14 |
| Simvastatin | 44 | $334 | $8 |
| Verapamil Er | 16 | $321 | $20 |
| Nifedipine Er | 11 | $242 | $22 |
| Chlorthalidone | 18 | $216 | $12 |
| Benazepril | 15 | $197 | $13 |
| Torsemide | 14 | $168 | $12 |
| Gabapentin | 11 | $74 | $7 |
| Amoxicillin | 16 | $30 | $2 |
2022: 46 drugs
| Eliquis | 391 | $438,383 | $1,121 |
| Vyndaqel | 13 | $249,009 | $19,155 |
| Entresto | 90 | $96,932 | $1,077 |
| Xarelto | 76 | $83,071 | $1,093 |
| Jardiance | 23 | $31,835 | $1,384 |
| Repatha Sureclick | 25 | $18,867 | $755 |
| Metoprolol | 395 | $8,470 | $21 |
| Atorvastatin | 566 | $7,758 | $14 |
| Losartan | 299 | $4,329 | $14 |
| Ezetimibe | 77 | $3,695 | $48 |
| Carvedilol | 226 | $3,401 | $15 |
| Diltiazem 24hr Er (Cd) | 75 | $3,391 | $45 |
| Rosuvastatin | 133 | $3,331 | $25 |
| Valsartan | 57 | $3,267 | $57 |
| Amiodarone | 87 | $2,688 | $31 |
| Digoxin | 53 | $2,270 | $43 |
| Potassium Chloride | 64 | $1,916 | $30 |
| Isosorbide Mononitrate Er | 52 | $1,558 | $30 |
| Amlodipine Besylate | 212 | $1,228 | $6 |
| Furosemide | 141 | $1,058 | $8 |
| Clopidogrel | 36 | $1,055 | $29 |
| Spironolactone | 94 | $1,045 | $11 |
| Ranolazine Er | 12 | $1,013 | $84 |
| Nitroglycerin | 39 | $1,010 | $26 |
| Chlorthalidone | 28 | $953 | $34 |
| Olmesartan Medoxomil | 23 | $923 | $40 |
| Warfarin | 47 | $907 | $19 |
| Lisinopril | 132 | $895 | $7 |
| Isosorbide Dinitrate | 12 | $743 | $62 |
| Metoprolol | 72 | $725 | $10 |
| Hydralazine | 54 | $572 | $11 |
| Spironolactone-Hctz | 19 | $555 | $29 |
| Levothyroxine | 21 | $539 | $26 |
| Pravastatin | 19 | $438 | $23 |
| Hydrochlorothiazide | 73 | $401 | $5 |
| Omeprazole | 12 | $386 | $32 |
| Pantoprazole | 12 | $380 | $32 |
| Allopurinol | 14 | $322 | $23 |
| Simvastatin | 45 | $299 | $7 |
| Irbesartan | 11 | $286 | $26 |
| Torsemide | 12 | $190 | $16 |
| Atenolol | 35 | $184 | $5 |
| Triamterene-Hydrochlorothiazid | 11 | $161 | $15 |
| Benazepril | 14 | $159 | $11 |
| Gabapentin | 13 | $84 | $6 |
| Amoxicillin | 20 | $35 | $2 |
2021: 45 drugs
| Eliquis | 408 | $373,410 | $915 |
| Vyndaqel | 12 | $218,025 | $18,169 |
| Xarelto | 59 | $67,988 | $1,152 |
| Entresto | 37 | $36,710 | $992 |
| Pradaxa | 12 | $11,347 | $946 |
| Metoprolol | 375 | $9,720 | $26 |
| Atorvastatin | 515 | $8,512 | $17 |
| Losartan | 325 | $5,586 | $17 |
| Diltiazem 24hr Er (Cd) | 78 | $4,481 | $57 |
| Ezetimibe | 68 | $3,389 | $50 |
| Rosuvastatin | 121 | $3,286 | $27 |
| Carvedilol | 224 | $3,252 | $15 |
| Amiodarone | 93 | $2,235 | $24 |
| Valsartan | 56 | $2,235 | $40 |
| Digoxin | 41 | $1,901 | $46 |
| Potassium Chloride | 65 | $1,638 | $25 |
| Isosorbide Mononitrate Er | 46 | $1,636 | $36 |
| Amlodipine Besylate | 199 | $1,337 | $7 |
| Lisinopril | 116 | $1,264 | $11 |
| Olmesartan Medoxomil | 26 | $1,167 | $45 |
| Spironolactone | 84 | $1,095 | $13 |
| Ranolazine Er | 12 | $993 | $83 |
| Warfarin | 40 | $936 | $23 |
| Isosorbide Dinitrate | 14 | $929 | $66 |
| Furosemide | 137 | $890 | $6 |
| Levothyroxine | 35 | $864 | $25 |
| Chlorthalidone | 28 | $814 | $29 |
| Midodrine | 13 | $801 | $62 |
| Nitroglycerin | 27 | $750 | $28 |
| Nifedipine Er | 16 | $736 | $46 |
| Metoprolol | 59 | $678 | $11 |
| Spironolactone-Hctz | 13 | $579 | $45 |
| Hydralazine | 43 | $571 | $13 |
| Hydrochlorothiazide | 82 | $559 | $7 |
| Simvastatin | 63 | $433 | $7 |
| Clopidogrel | 27 | $416 | $15 |
| Atenolol | 43 | $386 | $9 |
| Torsemide | 16 | $356 | $22 |
| Allopurinol | 11 | $257 | $23 |
| Lovastatin | 12 | $183 | $15 |
| Benazepril | 19 | $152 | $8 |
| Pravastatin | 14 | $149 | $11 |
| Gabapentin | 13 | $88 | $7 |
| Ramipril | 19 | $84 | $4 |
| Amoxicillin | 26 | $49 | $2 |
2020: 43 drugs
| Eliquis | 349 | $296,119 | $848 |
| Xarelto | 45 | $54,146 | $1,203 |
| Entresto | 30 | $28,008 | $934 |
| Metoprolol | 411 | $13,717 | $33 |
| Pradaxa | 13 | $12,381 | $952 |
| Atorvastatin | 581 | $10,740 | $18 |
| Losartan | 343 | $5,835 | $17 |
| Ezetimibe | 63 | $4,268 | $68 |
| Diltiazem 24hr Er (Cd) | 72 | $4,071 | $57 |
| Carvedilol | 224 | $3,361 | $15 |
| Rosuvastatin | 65 | $2,324 | $36 |
| Potassium Chloride | 71 | $2,187 | $31 |
| Digoxin | 48 | $2,154 | $45 |
| Amiodarone | 100 | $1,887 | $19 |
| Valsartan | 33 | $1,855 | $56 |
| Isosorbide Mononitrate Er | 53 | $1,613 | $30 |
| Lisinopril | 126 | $1,332 | $11 |
| Warfarin | 49 | $1,320 | $27 |
| Amlodipine Besylate | 181 | $1,275 | $7 |
| Olmesartan Medoxomil | 12 | $1,201 | $100 |
| Chlorthalidone | 28 | $1,110 | $40 |
| Furosemide | 147 | $1,006 | $7 |
| Spironolactone | 91 | $973 | $11 |
| Isosorbide Dinitrate | 13 | $966 | $74 |
| Levothyroxine | 32 | $944 | $30 |
| Bumetanide | 11 | $913 | $83 |
| Hydralazine | 54 | $843 | $16 |
| Nitroglycerin | 33 | $718 | $22 |
| Clopidogrel | 36 | $702 | $20 |
| Metoprolol | 74 | $691 | $9 |
| Atenolol | 53 | $622 | $12 |
| Simvastatin | 67 | $589 | $9 |
| Cartia Xt | 12 | $548 | $46 |
| Spironolactone-Hctz | 17 | $463 | $27 |
| Hydrochlorothiazide | 78 | $436 | $6 |
| Torsemide | 17 | $386 | $23 |
| Verapamil Er | 12 | $348 | $29 |
| Nifedipine Er | 12 | $337 | $28 |
| Pravastatin | 16 | $291 | $18 |
| Allopurinol | 11 | $198 | $18 |
| Benazepril | 17 | $159 | $9 |
| Gabapentin | 13 | $89 | $7 |
| Amoxicillin | 19 | $35 | $2 |
2019: 46 drugs
| Eliquis | 233 | $184,618 | $792 |
| Xarelto | 67 | $71,351 | $1,065 |
| Pradaxa | 39 | $28,696 | $736 |
| Metoprolol | 474 | $15,935 | $34 |
| Entresto | 15 | $13,801 | $920 |
| Atorvastatin | 552 | $12,276 | $22 |
| Losartan | 324 | $5,307 | $16 |
| Colchicine | 19 | $4,846 | $255 |
| Ezetimibe | 62 | $4,744 | $77 |
| Rosuvastatin | 60 | $3,987 | $66 |
| Carvedilol | 280 | $3,961 | $14 |
| Potassium Chloride | 81 | $3,298 | $41 |
| Amiodarone | 73 | $2,740 | $38 |
| Valsartan | 45 | $2,061 | $46 |
| Lisinopril | 157 | $1,818 | $12 |
| Diltiazem 24hr Er (Cd) | 50 | $1,716 | $34 |
| Bumetanide | 16 | $1,635 | $102 |
| Digoxin | 30 | $1,591 | $53 |
| Amlodipine Besylate | 197 | $1,453 | $7 |
| Warfarin | 61 | $1,399 | $23 |
| Furosemide | 183 | $1,167 | $6 |
| Spironolactone-Hctz | 24 | $1,105 | $46 |
| Nifedipine Er | 12 | $1,024 | $85 |
| Cartia Xt | 22 | $1,000 | $45 |
| Isosorbide Dinitrate | 13 | $996 | $77 |
| Isosorbide Mononitrate Er | 47 | $989 | $21 |
| Levothyroxine | 33 | $941 | $29 |
| Spironolactone | 79 | $854 | $11 |
| Simvastatin | 74 | $842 | $11 |
| Digox | 11 | $786 | $71 |
| Clopidogrel | 48 | $747 | $16 |
| Chlorthalidone | 20 | $673 | $34 |
| Metoprolol | 70 | $670 | $10 |
| Pravastatin | 25 | $641 | $26 |
| Nitroglycerin | 36 | $628 | $17 |
| Atenolol | 65 | $618 | $10 |
| Enalapril Maleate | 15 | $555 | $37 |
| Hydrochlorothiazide | 79 | $474 | $6 |
| Hydralazine | 42 | $460 | $11 |
| Benazepril | 22 | $361 | $16 |
| Torsemide | 14 | $293 | $21 |
| Ramipril | 18 | $207 | $12 |
| Sotalol | 16 | $194 | $12 |
| Allopurinol | 12 | $119 | $10 |
| Gabapentin | 12 | $83 | $7 |
| Amoxicillin | 16 | $34 | $2 |
2018: 40 drugs
| Eliquis | 166 | $124,081 | $747 |
| Xarelto | 68 | $53,391 | $785 |
| Pradaxa | 70 | $47,989 | $686 |
| Metoprolol | 416 | $15,933 | $38 |
| Atorvastatin | 611 | $14,962 | $24 |
| Ezetimibe | 53 | $9,698 | $183 |
| Potassium Chloride | 85 | $5,888 | $69 |
| Losartan | 372 | $4,655 | $13 |
| Carvedilol | 288 | $3,302 | $11 |
| Bumetanide | 25 | $3,041 | $122 |
| Valsartan | 38 | $2,981 | $78 |
| Diltiazem 24hr Er (Cd) | 35 | $2,941 | $84 |
| Rosuvastatin | 28 | $2,548 | $91 |
| Digox | 34 | $2,405 | $71 |
| Isosorbide Mononitrate Er | 80 | $2,226 | $28 |
| Digoxin | 26 | $2,158 | $83 |
| Amiodarone | 63 | $2,046 | $32 |
| Lisinopril | 204 | $1,865 | $9 |
| Amlodipine Besylate | 179 | $1,351 | $8 |
| Warfarin | 60 | $1,166 | $19 |
| Nitroglycerin | 43 | $1,123 | $26 |
| Spironolactone-Hctz | 15 | $1,052 | $70 |
| Pravastatin | 44 | $1,027 | $23 |
| Clopidogrel | 50 | $1,009 | $20 |
| Levothyroxine | 36 | $1,003 | $28 |
| Cartia Xt | 28 | $911 | $33 |
| Furosemide | 155 | $878 | $6 |
| Simvastatin | 81 | $824 | $10 |
| Metoprolol | 88 | $805 | $9 |
| Enalapril Maleate | 17 | $754 | $44 |
| Atenolol | 69 | $700 | $10 |
| Spironolactone | 72 | $693 | $10 |
| Chlorthalidone | 18 | $563 | $31 |
| Hydralazine | 32 | $468 | $15 |
| Hydrochlorothiazide | 88 | $408 | $5 |
| Benazepril | 22 | $297 | $13 |
| Ramipril | 13 | $292 | $22 |
| Pantoprazole | 11 | $274 | $25 |
| Triamterene-Hydrochlorothiazid | 13 | $128 | $10 |
| Amoxicillin | 12 | $32 | $3 |
2017: 45 drugs
| Eliquis | 139 | $78,704 | $566 |
| Pradaxa | 52 | $34,340 | $660 |
| Xarelto | 44 | $29,976 | $681 |
| Metoprolol | 374 | $13,869 | $37 |
| Atorvastatin | 588 | $12,366 | $21 |
| Zetia | 12 | $9,114 | $760 |
| Ezetimibe | 23 | $6,953 | $302 |
| Potassium Chloride | 62 | $4,134 | $67 |
| Losartan | 328 | $3,435 | $10 |
| Valsartan | 38 | $3,199 | $84 |
| Carvedilol | 278 | $2,821 | $10 |
| Digox | 31 | $2,624 | $85 |
| Digoxin | 35 | $2,261 | $65 |
| Diltiazem 24hr Er | 48 | $1,971 | $41 |
| Bumetanide | 16 | $1,903 | $119 |
| Lisinopril | 223 | $1,893 | $8 |
| Isosorbide Mononitrate Er | 70 | $1,775 | $25 |
| Warfarin | 82 | $1,546 | $19 |
| Rosuvastatin | 17 | $1,505 | $89 |
| Nitroglycerin | 47 | $1,467 | $31 |
| Raloxifene | 12 | $1,447 | $121 |
| Amlodipine Besylate | 217 | $1,315 | $6 |
| Nifedipine Er | 34 | $1,313 | $39 |
| Amiodarone | 77 | $1,059 | $14 |
| Spironolactone-Hctz | 20 | $1,013 | $51 |
| Cartia Xt | 44 | $981 | $22 |
| Levothyroxine | 33 | $947 | $29 |
| Clopidogrel | 42 | $934 | $22 |
| Furosemide | 141 | $809 | $6 |
| Simvastatin | 95 | $781 | $8 |
| Metoprolol | 95 | $761 | $8 |
| Pravastatin | 34 | $702 | $21 |
| Spironolactone | 76 | $648 | $9 |
| Atenolol | 76 | $583 | $8 |
| Enalapril Maleate | 13 | $562 | $43 |
| Ramipril | 16 | $394 | $25 |
| Hydralazine | 13 | $361 | $28 |
| Omeprazole | 13 | $359 | $28 |
| Hydrochlorothiazide | 90 | $358 | $4 |
| Benazepril | 26 | $224 | $9 |
| Lovastatin | 12 | $217 | $18 |
| Triamterene-Hydrochlorothiazid | 21 | $177 | $8 |
| Allopurinol | 15 | $173 | $12 |
| Verapamil Er | 12 | $117 | $10 |
| Amoxicillin | 18 | $37 | $2 |
2016: 44 drugs
| Pradaxa | 61 | $33,517 | $549 |
| Eliquis | 46 | $26,014 | $566 |
| Xarelto | 27 | $24,840 | $920 |
| Zetia | 22 | $12,881 | $585 |
| Atorvastatin | 548 | $11,697 | $21 |
| Metoprolol | 329 | $11,686 | $36 |
| Ranexa | 15 | $6,179 | $412 |
| Valsartan | 39 | $5,496 | $141 |
| Carvedilol | 282 | $3,113 | $11 |
| Diltiazem 24hr Er | 34 | $2,984 | $88 |
| Potassium Chloride | 78 | $2,601 | $33 |
| Losartan | 248 | $2,496 | $10 |
| Nitrostat | 54 | $1,992 | $37 |
| Lisinopril | 222 | $1,853 | $8 |
| Digox | 41 | $1,758 | $43 |
| Warfarin | 122 | $1,729 | $14 |
| Amlodipine Besylate | 200 | $1,531 | $8 |
| Digoxin | 31 | $1,522 | $49 |
| Benicar | 11 | $1,504 | $137 |
| Nifedipine Er | 23 | $1,249 | $54 |
| Raloxifene | 12 | $1,167 | $97 |
| Isosorbide Mononitrate Er | 55 | $1,159 | $21 |
| Amiodarone | 92 | $1,104 | $12 |
| Spironolactone-Hctz | 17 | $1,064 | $63 |
| Pravastatin | 33 | $958 | $29 |
| Furosemide | 166 | $885 | $5 |
| Spironolactone | 89 | $845 | $9 |
| Simvastatin | 114 | $838 | $7 |
| Bumetanide | 19 | $783 | $41 |
| Levothyroxine | 33 | $773 | $23 |
| Enalapril Maleate | 13 | $725 | $56 |
| Cartia Xt | 29 | $659 | $23 |
| Clopidogrel | 32 | $641 | $20 |
| Metoprolol | 82 | $625 | $8 |
| Diltiazem 24hr Cd | 13 | $590 | $45 |
| Atenolol | 88 | $580 | $7 |
| Hydrochlorothiazide | 106 | $509 | $5 |
| Hydralazine | 12 | $474 | $39 |
| Omeprazole | 16 | $466 | $29 |
| Ramipril | 22 | $370 | $17 |
| Lovastatin | 20 | $334 | $17 |
| Terazosin | 25 | $325 | $13 |
| Propafenone | 15 | $324 | $22 |
| Benazepril | 28 | $300 | $11 |
2015: 45 drugs
| Xarelto | 47 | $34,455 | $733 |
| Pradaxa | 59 | $29,955 | $508 |
| Metoprolol | 289 | $12,554 | $43 |
| Atorvastatin | 447 | $10,305 | $23 |
| Crestor | 13 | $7,351 | $565 |
| Valsartan | 37 | $6,695 | $181 |
| Zetia | 13 | $6,486 | $499 |
| Ranexa | 14 | $6,031 | $431 |
| Spiriva | 14 | $4,489 | $321 |
| Carvedilol | 295 | $3,355 | $11 |
| Diltiazem 24hr Er | 25 | $3,000 | $120 |
| Potassium Chloride | 89 | $2,744 | $31 |
| Digox | 62 | $2,702 | $44 |
| Losartan | 197 | $2,036 | $10 |
| Nitrostat | 83 | $1,771 | $21 |
| Benicar | 13 | $1,753 | $135 |
| Warfarin | 88 | $1,531 | $17 |
| Lisinopril | 198 | $1,431 | $7 |
| Furosemide | 259 | $1,277 | $5 |
| Raloxifene | 12 | $1,249 | $104 |
| Amlodipine Besylate | 186 | $1,231 | $7 |
| Pravastatin | 40 | $1,223 | $31 |
| Digoxin | 28 | $1,129 | $40 |
| Toprol Xl | 14 | $1,065 | $76 |
| Enalapril Maleate | 26 | $1,036 | $40 |
| Nifedipine Er | 17 | $1,032 | $61 |
| Isosorbide Mononitrate Er | 46 | $1,023 | $22 |
| Simvastatin | 119 | $903 | $8 |
| Spironolactone-Hctz | 30 | $898 | $30 |
| Metoprolol | 97 | $811 | $8 |
| Amiodarone | 70 | $719 | $10 |
| Cartia Xt | 29 | $707 | $24 |
| Spironolactone | 80 | $703 | $9 |
| Clopidogrel | 64 | $703 | $11 |
| Propafenone | 20 | $677 | $34 |
| Hydralazine | 19 | $655 | $34 |
| Ramipril | 21 | $635 | $30 |
| Levothyroxine | 23 | $570 | $25 |
| Atenolol | 87 | $506 | $6 |
| Amlodipine Besylate-Benazepril | 12 | $468 | $39 |
| Hydrochlorothiazide | 90 | $394 | $4 |
| Omeprazole | 21 | $368 | $18 |
| Benazepril | 24 | $343 | $14 |
| Lovastatin | 21 | $334 | $16 |
| Diltiazem Er | 11 | $170 | $15 |
2014: 45 drugs
| Pradaxa | 55 | $22,487 | $409 |
| Xarelto | 45 | $17,035 | $379 |
| Metoprolol | 246 | $12,420 | $50 |
| Diovan | 21 | $11,981 | $571 |
| Atorvastatin | 441 | $11,974 | $27 |
| Crestor | 13 | $5,754 | $443 |
| Zetia | 14 | $5,636 | $403 |
| Multaq | 12 | $4,774 | $398 |
| Carvedilol | 288 | $4,058 | $14 |
| Losartan | 195 | $3,193 | $16 |
| Digox | 46 | $2,502 | $54 |
| Evista | 12 | $2,451 | $204 |
| Potassium Chloride | 60 | $2,330 | $39 |
| Lisinopril | 221 | $1,710 | $8 |
| Amlodipine Besylate | 191 | $1,634 | $9 |
| Pravastatin | 53 | $1,477 | $28 |
| Clopidogrel | 81 | $1,381 | $17 |
| Simvastatin | 139 | $1,253 | $9 |
| Toprol Xl | 17 | $1,227 | $72 |
| Nifedipine Er | 21 | $1,188 | $57 |
| Isosorbide Mononitrate Er | 55 | $1,123 | $20 |
| Ramipril | 21 | $1,103 | $53 |
| Hydralazine | 42 | $1,094 | $26 |
| Spironolactone-Hctz | 34 | $1,054 | $31 |
| Warfarin | 75 | $1,033 | $14 |
| Metoprolol | 104 | $863 | $8 |
| Propafenone | 20 | $862 | $43 |
| Spironolactone | 93 | $856 | $9 |
| Amiodarone | 61 | $819 | $13 |
| Digoxin | 14 | $807 | $58 |
| Furosemide | 191 | $749 | $4 |
| Nitrostat | 45 | $743 | $17 |
| Atenolol | 101 | $551 | $5 |
| Amlodipine Besylate-Benazepril | 13 | $547 | $42 |
| Levothyroxine | 21 | $527 | $25 |
| Benazepril | 26 | $512 | $20 |
| Enalapril Maleate | 18 | $510 | $28 |
| Klor-Con 10 | 26 | $501 | $19 |
| Diltiazem 24hr Er | 13 | $479 | $37 |
| Lovastatin | 24 | $426 | $18 |
| Triamterene-Hydrochlorothiazid | 11 | $367 | $33 |
| Hydrochlorothiazide | 77 | $342 | $4 |
| Diltiazem Er | 12 | $228 | $19 |
| Omeprazole | 15 | $198 | $13 |
| Clonidine | 11 | $59 | $5 |
2013: 47 drugs
| Pradaxa | 76 | $28,097 | $370 |
| Diovan | 43 | $17,368 | $404 |
| Atorvastatin | 394 | $16,426 | $42 |
| Metoprolol | 258 | $13,987 | $54 |
| Xarelto | 21 | $7,017 | $334 |
| Zetia | 29 | $4,721 | $163 |
| Ranexa | 11 | $4,317 | $392 |
| Carvedilol | 199 | $3,727 | $19 |
| Losartan | 156 | $3,718 | $24 |
| Clopidogrel | 82 | $3,416 | $42 |
| Diltiazem 24hr Cd | 38 | $3,274 | $86 |
| Potassium Chloride | 77 | $3,091 | $40 |
| Benicar | 11 | $2,906 | $264 |
| Amlodipine Besylate | 209 | $2,173 | $10 |
| Lisinopril | 264 | $2,151 | $8 |
| Simvastatin | 187 | $2,116 | $11 |
| Isosorbide Mononitrate Er | 68 | $1,395 | $21 |
| Hydralazine | 52 | $1,289 | $25 |
| Nitrostat | 84 | $1,215 | $14 |
| Nifedipine Er | 17 | $1,163 | $68 |
| Toprol Xl | 16 | $1,137 | $71 |
| Diltiazem 24hr Er | 23 | $1,079 | $47 |
| Metoprolol | 102 | $972 | $10 |
| Diltiazem Er | 16 | $922 | $58 |
| Propafenone | 19 | $913 | $48 |
| Warfarin | 83 | $912 | $11 |
| Pravastatin | 30 | $852 | $28 |
| Amiodarone | 55 | $793 | $14 |
| Hydrochlorothiazide | 112 | $760 | $7 |
| Furosemide | 183 | $760 | $4 |
| Atenolol | 99 | $747 | $8 |
| Spironolactone | 54 | $687 | $13 |
| Ramipril | 12 | $610 | $51 |
| Enalapril Maleate | 35 | $589 | $17 |
| Digox | 45 | $571 | $13 |
| Benazepril | 25 | $546 | $22 |
| Lovastatin | 34 | $515 | $15 |
| Klor-Con 10 | 15 | $505 | $34 |
| Spironolactone-Hctz | 18 | $478 | $27 |
| Levothyroxine | 25 | $446 | $18 |
| Lanoxin | 18 | $371 | $21 |
| Triamterene-Hctz | 21 | $329 | $16 |
| Omeprazole | 18 | $225 | $12 |
| Pantoprazole | 17 | $214 | $13 |
| Digoxin | 12 | $197 | $16 |
| Terazosin | 13 | $130 | $10 |
| Clonidine | 11 | $64 | $6 |
Money from drug and device companies
$181 in 2025
| 2025 | 2 | 3 | None | $181 |
| 2024 | 1 | 1 | None | $129 |
| 2019 | 1 | 1 | None | $125 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| E.R. Squibb & Sons L.L.C. | Camzyos | $151 | 2 payments
|
| Novartis Pharmaceuticals | Leqvio | $30 | 1 payment
|
See all 3 published payments
| E.R. Squibb & Sons L.L.C. | Meals · 2025-12-02 | Eliquis | $29 |
| Novartis Pharmaceuticals | Meals · 2025-07-31 | Leqvio | $30 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-04-30 | Camzyos | $122 |
See earlier years (2024, 2019)
2024: $129
| Impulse Dynamics (USA) | Optimizer | $129 | 1 payment
|
2019: $125
| Alnylam Pharmaceuticals | Onpattro | $125 | 1 payment
|
Professional record
- NPI
- 1982615837
- Licence
- CA A60327California A60327: Current · expires 2028-06-30
- Trained
- Harvard Medical School, 1994
- Group
- Stanford Health Care · Sutter Bay Medical Foundation
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Cardiology (207RC0000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2006-08-10
- NPI last updated
- 2024-05-06
- NPI record certified
- 2024-05-06
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 795 El Camino Real, Palo Alto, CA, 94301